A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease

Clinical trial NCT00866359 · COMPLETED

Trial details

NCT number: NCT00866359
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet Syndrome

Start date: 2009-08-01
Primary completion: 2012-05-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.